Acute and chronic animal models for the evaluation of anti-diabetic agents

Cardiovascular Diabetology

Volumn 11, Issue , 2012, Pages

  Kumar, Suresh ^a   Singh, Rajeshwar ^a   Vasudeva, Neeru ^a   Sharma, Sunil ^a  

^a GURU JAMBHESHWAR UNIVERSITY OF SCIENCE AND TECHNOLOGY   (India)

Author keywords

Alloxan; Animal models; Diabetes; Diabetic rats; Streptozotocin

Indexed keywords

ALLOXAN; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; HORMONE; STREPTOZOCIN; BIOLOGICAL MARKER;

CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CHINESE HAMSTER; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE SEVERITY; DOG; EXPERIMENTAL ANIMAL; GLUCOSE BLOOD LEVEL; HEART FAILURE; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PANCREAS RESECTION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREGNANCY DIABETES MELLITUS; REVIEW; STREPTOZOCIN DIABETES; STROKE; TRANSIENT ISCHEMIC ATTACK; VIRUS; WISTAR RAT; ZUCKER DIABETIC FATTY RAT; ACUTE DISEASE; ANIMAL; BLOOD; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; EXPERIMENTAL DIABETES MELLITUS; GENETICS; HUMAN; METABOLISM; SPECIES DIFFERENCE; TRANSGENIC ANIMAL;

ACUTE DISEASE; ANIMALS; ANIMALS, GENETICALLY MODIFIED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETES MELLITUS, EXPERIMENTAL; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; SPECIES SPECIFICITY;

EID: 84855898684     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-11-9     Document Type: Review

References (114)

1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998, 21:1414-1431. 10.2337/diacare.21.9.1414, 9727886.
2. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 1997, 14(5):1-85.
3. IDF Diabetes Atlas 2009, International Diabetes Federation, 4.
4. Mohan V, Pradeepa R. Epidemiology of diabetes in different regions of India. Health Administrator 2009, 22:1-18.
5. Rother KI. Diabetes treatment--bridging the divide". The New England Journal of Medicine 2007, 356(15):1499-501. 10.1056/NEJMp078030, 17429082.
6. Other types of diabetes. 2005, American Diabetes Association.
7. Handelsman Yehuda MD. A Doctor's Diagnosis: Prediabetes. Power of Prevention 2009, 1(2):1.
8. "Diseases: Johns Hopkins Autoimmune Disease Research Center". Retrieved 2007-09-23.
9. World Health Organisation. Department of Noncommunicable Disease Surveillance 1999, "Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications", World Health Organisation. Department of Noncommunicable Disease Surveillance.
10. Potenza MA, Nacci C, Gagliardi S, Montagnani M. Cardiovascular complications in diabetes: lessons from animal models. Curr Med Chem 2011, 18:1806-19. 10.2174/092986711795496755, 21466471.
11. Rastellini C, Shapiro R, Corry R, Fung JJ, Starzl TE, Rao AS. An attempt to reverse diabetes by delayed islet cell transplantation in Humans. Transplantation 1997, 29:2238-2239.
12. Rydgren T, Vaarala O, Sandler S. Simvastatin protects against multiple low dose streptozotocin in-duced type 1 diabetes in CD-1 mice and recurrence of the disease in nonobese diabetic mice. J Pharma-col Expt Ther 2007, 23:180-185.
13. Balamurugan AN, Miyamoto M, Wang W, Inoue K, Tabata Y. Streptozotocin (STZ) used to in-duce diabetes in animal models. J Ethnopharm 2003, 26:102-103.
14. Hayashi K, Kojima R, Ito M. Strain differences in the diabetogenic activity of streptozotocin in mice. Biol Pharmaceut Bull 2006, 29:1110-1119.
15. Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 2001, 50:537-46.
16. Takeshita F, Kodama M, Yamamoto H, Ikarashi Y, Ueda S, Teratani T, Yamamoto Y, Tamatani T, Kanegasaki S, Ochiya T, Quinn G. Streptozotocin-induced partial beta cell depletion in nude mice without hyperglycaemia induces pancreatic morphogenesis in transplanted embryonic stem cells. Diabetologia 2006, 49:2948-58. 10.1007/s00125-006-0432-z, 17047919.
17. Weiss RB. Streptozotocin: A review of its pharmacology, efficacy and toxicity. Canc Treat Rep 1982, 66:427-438.
18. Brosky G, Logothetopoulos J. Streptozotocin diabetes in the mouse and guinea pig. Diabetes 1969, 8:606-611.
19. Ito M. New model of progressive non-insulin-dependent diabetes mellitus in mice induced by Streptozotocin. Biol Pharmaceut Bull 1999, 22:988-989.
20. Ikebukuro K, Adachi Y, Yamada Y, Fujimoto S, Seino Y, Oyaizu H. Treatment of Streptozotocin-induced diabetes mellitus by transplantation of islet cells Plus bone Marrow cells via portal vein in rats. Transplantation 2002, 73:512-518. 10.1097/00007890-200202270-00004, 11889421.
21. Smith SB, Prior RL, Mersmann HJ. Interrelationship between insulin and lipid metabolism in normal and alloxan-diabetic cattle. J Nutr 1983, 113:1002-1015.
22. Viana GS, Medeiros AC, Lacerda AM, Leal LK, Vale TG, Matos FJ. Hypoglycemic and anti-lipidemic effects of the aqueous extract of Cissus si-cyoides. BMC Pharmacol 2004, 8:4-9.
23. Szkudelski T. The mechanism of alloxan and streptozotocin action β cells of the rat pancreas. Physiology Res 2001, 50:536-546.
24. Bartosikova L, Nieces J, Succhy V, Kubinov R, Vesa-la D, Benes L. Monitoring of antoxidative effect of morine in alloxan-induced diabetes mellitus in the laboratory rat. Acta Vet Bull 2003, 72:191-200.
25. Takasu N, Asawa T, Komiya I, Nagasawa Y, Yama-da T. Alloxan induced DNA strand breaks in pancreatic islets. Journal of Biochemistry 1991, 266:2112-2114.
26. Masiello P. Animal models of type11 diabetes with reduced pancreatic β-cell mass. The interna-tional Journal of Biochemistry and Cell Biology 2006, 38:873-893.
27. Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002, 48:436-472.
28. Nathan DM, Turgeon H, Regans S. Relationship between Glycated haemoglobin levels and mean glucose levels over time. Diabetologia 2007, 50:2239-2244. 10.1007/s00125-007-0803-0, 17851648.
29. Barrett-Connor E, Wingard DL. Sex differential in ischemic heart disease mortality in diabetics: a prospective population-based study. Am J Epidemiol 1983, 118:489-96.
30. Donahue RP, Abbott RD, Reed DM, Yano K. Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry. Honolulu Heart Program Diabetes 1987, 36:689-92.
31. Harris M, Entmacher PS. Mortality from diabetes. 1985, 1-48. Diabetes in America. U.S. Government Printing Office, NIH, Harris Ml, Hamman RF.
32. Wetterhall SF, Olson DR, DeStefano F, Stevenson JM, Ford ES, German RR. Trends in diabetes and diabetic complications, 1980-1987. Diabetes Care 1992, 15:960-967. 10.2337/diacare.15.8.960, 1324144.
33. Vogel HG, Vogel WH. Drug discovery and evaluation: pharmacological assays. 2002, 948-1051. Springer-Verlag Berlin Heidelberg, New York, Herling AW: Antidiabetic activity.
34. Banting FG, Best CH. The internal secretion of the pancreas. J Lab Clin Med 1922, 7:251-266.
35. Foa PP. Pankreatektomie. Dörzbach Handbook of experimental Pharmacology 1971, 32/1:146-158. Insulin, Springer-Verlag, Berlin Heidelberg New York.
36. Sirek A. Pancreatectomy and diabetes. Handbook of Diabetes mellitus, Pathophysiology and clinical Considerations 1968, I:727-743. Lehmanns Verlag, München, Pfeiffer EF.
37. Frerichs H, Creutzfeldt W. Der experimentelle chemische Diabetes. Handbook of Experimental Pharmacology 1971, 32/1:159-202. Insulin, Springer-Verlag, Berlin Heidelberg New York, Dörzbach E.
38. Tasaka Y, Inoue Y, Matsumoto H, Hirata Y. Changes in plasma glucagon, pancreatic polypeptide and insulin during development of alloxan diabetes mellitus in dog. Endocrinol Japon 1988, 35:399-40.
39. Baily CC, Baily OT. Production of diabetes mellitus inrabbits with alloxan. A preliminary report. J Am Med 1943, 122:1165-1166.
40. Goldner MG, Gomori G. Studies on the mechanism of alloxan diabetes. Endocrinology 1944, 35:241-248.
41. Frerichs H, Creutzfeldt W. Diabetes durch Beta-Zytotoxine. Handbook of Diabetes mellitus, Pathophysiology and Clinical Considerations 1968, I:811-840. LehmannsVerlag, München, Pfeiffer EF.
42. Maske H, Weinges K. Untersuchungen über das Verhalten der Meerschweinchen gegenüber verschiedenen diabetogenen Noxen. Alloxan und Dithizon. Naunyn-Schmiedeberg's Arch exper Path Pharmakol 1957, 230:406-420.
43. Bänder A, Pfaff W, Schmidt FH, Stork H, Schröder HG. Zur Pharmakologie von HB 419, einem neuen, starwirksamenoralen Antidiabeticum. Arzneim Forsch Drug Res 1969, 19:1363-1372.
44. Katsumata K, Katsumata Y, Ozawa T, Katsumata JR. Potentiating effect of combined usage of three sulfonylurea drugs on the occurrence of alloxan diabetes in rats. Horm Metab Res 1993, 25:125-126. 10.1055/s-2007-1002058, 8458609.
45. Geisen K. Special pharmacology of the new sulfonylurea glimepiride. Arzneim Forsch Drug Res 1988, 38:1120-1130.
46. Kodoma T, Iwase M, Nunoi K, Maki Y, Yoshinari M, Fujishima M. A new diabetes model induced by neonatal alloxan treatment in rats. Diab Res Clin Pract 1993, 20:183-189.
47. Rakieten N, Rakieten ML, Nadkarni MV. Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemother Rep 1963, 29:91-102.
48. Masutani M, Suzuki H, Kamada N, Watanabe M, Ueda O, Jishage K-I, Watanabe T, Sugimoto T, Nakagama H, Sugimura T. Poly(ADP-ribose)polymerase gene disruptionconferred mice resistant to streptozotocin-induced diabetes. Proc Natl Acad Sci 1998, (96):2301-2304.
49. Cotes PM, Reid E, Young FG. Diabetogenic action of pure anterior pituitary growth hormone. Nature 1949, 164:209-211. 10.1038/164209a0, 18135939.
50. Young FG. Growth and diabetes in normal animals treated with pituitary (anterior lobe) diabetogenic extract. Biochem J 1941, 39:515-536.
51. Ingle DJ. The production of glycosuria in the normal rat by means of 17-hydroxy-11-dehydrocorticosterone. Endocrinology 1941, 29:649-652.
52. Abelove WA, Paschkis KE. Comparison of the diabetogenic action of cortisone and growth hormone in different species. Endocrinology 1994, 55:637-654.
53. Ingle DJ, Li CH, Evans HM. The effect of adrenocorticotropic hormone on the urinary excretion of sodium, chloride, potassium, nitrogen and glucose in normal rats. Endocrinology 1946, 39:32-39. 10.1210/endo-39-1-32, 20996018.
54. Craighead J. Current views on the etiology of insulin-dependent diabetes mellitus. New Engl J Med 1978, 299:1439-1445. 10.1056/NEJM197812282992605, 362209.
55. Vialettes B, Baume D, Charpin C, De Maeyer-Guignard J, Vague P. Assessment of viral and immune factors in EMC virus- induced diabetes: effects of cyclosporin A and interferon. J Lab Clin Immunol 1983, 10:35-40.
56. Hansen WA, Christie MR, Kahn R, Norgard A, Abel I, Petersen AM, Jorgensen DW, Baekkeskov S, Nielsen JH, Lernmark A, Egeberg J, Richter-Olesen H, Grainger T, Kristensen JK, Brynitz S, Bilde T. Supravital dithizone staining in the isolation of human and rat pancreatic islets. Diabetes Res 1989, 10:53-57.
57. Heydrick SJ, Gautier N, Olichon-Berte C, Van Obberghen E, Le Marchand Brustel Y. Early alteration of insulin stimulation of PI 3-kinase in muscle and adipocyte from gold thioglucose obese mice. Am J Physiol Endocrinol Metab 1995, 268:604-612.
58. Sartin JL, Lamperti AA, Kemppainen RJ. Alterations in insulin and glucagon secretion by monosodium glutamate lesions of the hypothalamic arcuate nucleus. Endocr Res 1985, 11:145-155.
59. Goldberg ED, Eshchenko VA, Bovt VD. The diabetogenic and acidotropic effects of chelators. Exp Pathol 1991, 42:59-64. 10.1016/S0232-1513(11)80038-1, 1879512.
60. Wright PH. Experimental insulin-deficiency due to insulin antibodies. Handbook of Diabetes mellitus, Pathophysiology and Clinical Considerations 1968, I:841-865. Lehmanns Verlag, München, Pfeiffer EF.
61. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JF. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432. 10.1038/372425a0, 7984236.
62. Friedman JF, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998, 395:763-770. 10.1038/27376, 9796811.
63. Ellerman K, Wroblewski M, Rabinovitch A, Like A. Natural killer cell depletion and diabetes mellitus in the BB/Wor rat. Diabetologia 1993, 36:596-601. 10.1007/BF00404067, 7689498.
64. Hao L, Chan SM, Lafferty KJ. Mycophenolate mofetil can prevent the development of diabetes in BB rats. Ann NY Acad Sci 1993, 969:328-332.
65. Klöting I, Vogt L. BB/O(TTAWA)K(ARLSBURG) rats:features of a subline of diabetes prone BB rats. Diabetes Res 1991, 18:79-87.
66. Yagihashi S, Wada RI, Kamijo M, Nagai K. Peripheral neuropathy in the WBN/Kob rat with chronic pancreatitis and spontaneous diabetes. Lab Invest 1993, 68:296-307.
67. Cohen AM, Teitelbaum A, Saliternik R. Genetics and diet as factors in the development of diabetes mellitus. Metabolism 1972, 21:235-240.
68. Velasquez MT, Kimmel PL, Michaelis OE. Animal models of spontaneous diabetic kidney disease. FASEB J 1972, 4:2850-2859.
69. Begum N, Ragiola L. Altered regulation of insulin signaling components in adipocytes of insulin-resistant type II diabetic Goto-Kakizaki rats. Metabolisms 1998, 47:54-62.
70. Zucker LM. Hereditary obesity in the rat associated with hyperlipidemia. Ann NY Acad Sci 1965, 131:447-458. 10.1111/j.1749-6632.1965.tb34810.x, 5216982.
71. Galante P, Maerker E, Scholz R, Rett K, Herberg L, Mosthaf L, Häring HU. Insulin-induced translocation of GLUT 4 in skeletal muscle of insulin-resistant Zucker rats. Diabetologia 1994, 37:3-9. 10.1007/BF00428770, 8150226.
72. Peterson RG, Shaw WN, Neel M-AN, Little LA, Eicheberg J. Zucker Diabetic Fatty rat as a model for non-insulindependent diabetes mellitus. ILAR News 1990, 32:16-19.
73. Lee Y, Hirose H, Ohneda M, Johnson JH, McGarry JD, Unger RH. β-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocytes-β-cell relationships. Proc Natl Acad Sci 1994, 91:10878-10882. 10.1073/pnas.91.23.10878, 45129, 7971976.
74. Velasquez MT, Kimmel PL, Michaelis OE. Animal models of spontaneous diabetic kidney disease. FASEB J 1990, 4:2850-2859.
75. Ishida K, Mizuno A, Sano T, Shima K. Which is the primary etiologic event in Otsuka Long-Evans Tokushima fatty rats, a model of spontaneous non-insulin-dependent diabetes mellitus, insulin resistance, or impaired insulin secretion?. Metabolism 1995, 44:940-945. 10.1016/0026-0495(95)90249-X, 7616855.
76. Tarrés MC, Martínez SM, Liborio MM, Rabasa SL. Diabetes mellitus en una línea endocrinada de rata. Mendeliana 1981, 5:39-48.
77. Dumm CLAG, Semino MC, Gagliardino JJ. Sequential changes in pancreatic islets of spontaneously diabetic rats. Pancreas 1990, 5:533-539. 10.1097/00006676-199009000-00007, 1978314.
78. Koletsky S. Pathologic findings and laboratory data in a new strain of obese hypertensive rats. Am J Pathol 1975, 80:129-142. 1912834, 1171627.
79. Russell JC, Graham S, Hameed M. Abnormal insulin and glucose metabolism in the JCR:LA-corpulent rat. Metabolism 1994, 43:538-543. 10.1016/0026-0495(94)90192-9, 8177040.
80. Friedman JE, Ishizuka T, Liu S, Farrell CJ, Bedol D, Koletsky RJ, Kaung HL, Ernsberger P. Reduced insulin receptor signaling in the obese spontaneously hypertensive Koletsky rat. Am J Physiol Endocrinol Metab 1997, 273:E1014-1023.
81. Adamo M, Shemer J, Aridor M, Dixon J, Carswell N, Bhathena SJ, Michaelis OE, LeRoith D. Liver insulin receptor tyrosine kinase activity in a model of type II diabetes mellitus and obesity. J Nutr 1989, 119:484-489.
82. Velasquez MT, Kimmel PL, Michaelis OE. Animal models of spontaneous diabetic kidney disease. FASEB J 1990, 4:2850-2859.
83. Nakamura M, Yamada K. Studies on a diabetic (KK) strain of the mouse. Diabetologia 1967, 3:212-221. 10.1007/BF01222198, 4907141.
84. Iwatsuka H, Shino A, Suzouki Z. General survey of diabetic features of yellow KK mice. Endocrinol Japon 1970, 17:23-35.
85. Diani AR, Sawada GA, Zhang NY, Wyse BM, Connell CL, Vidmar TJ, Connell MA. The KKAy mouse: a model for the rapid development of glomerular capillary basement membrane thickening. Blood Vessels 1987, 24:297-303.
86. Baeder WL, Sredy J, Sehgal SN, Chang JY, Adams LM. Rapamycin prevents the onset of insulin dependent diabetes mellitus (IDDM) in NOD mice. Clin Exp Immunol 1992, 89:174-178. 1554419, 1638761.
87. Nicoletti F, Di Marco R, Barcellini W, Magro G, Schorlemmer HU, Kurrle R, Lunetta M, Grasso S, Zaccone P, Meroni PL. Protection from experimental autoimmune diabetes in the non-obese diabetic mouse with soluble interleukin-1 receptor. Eur J Immunol 1994, 24:1843-1847. 10.1002/eji.1830240818, 8056041.
88. Verdaguer J, Schmidt D, Amrani A, Anderson B, Averill N, Santamaria P. Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J Exp Med 1997, 186:1663-1676. 10.1084/jem.186.10.1663, 2199139, 9362527.
89. Bleisch VR, Mayer J, Dickie MM. Familial diabetes mellitus in mice associated with insulin resistance, obesity and hyperplasia of the islands of Langerhans. Am J Pathol 1952, 28:369-385. 1937350, 14923830.
90. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM. Weightreducing effects of the plasma protein encoded by the obesegene. Science 1995, 269:543-546. 10.1126/science.7624777, 7624777.
91. Herberg L, Coleman DL. Laboratory animals exhibiting obesity and diabetes syndromes. Metabolism 1977, 26:59-99. 10.1016/0026-0495(77)90128-7, 834144.
92. Tartaglia LA, Dembski M, Wenig X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J. Identification and expression cloning of a leptin receptor, OB-R. Cell 1995, 83:1263-1271. 10.1016/0092-8674(95)90151-5, 8548812.
93. Like AA, Lavine RL, Poffenbarger PL, Chick WI. Studies on the diabetic mutant mouse. VI Evolution of glomerular lesions and associated proteinuria. Am J Pathol 1972, 66:193-224. 2032492, 5009970.
94. Friedman JF, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998, 395:763-770. 10.1038/27376, 9796811.
95. Connelly DM, Taberner PV. Characterization of spontaneous diabetes obesity syndrome in mature CBA/Ca mice. Pharmacol Biochem Behav 1989, 34:255-259. 10.1016/0091-3057(89)90308-0, 2695942.
96. Jones E. Spontaneous hyperplasia of the pancreatic islets associated with glycosuria in hybrid mice. The structure and metabolism of pancreatic islets 1964, 189-191. Pergamon Press, Oxford, Brolin SE, Hellman B, Knutson H.
97. Like AA, Jones EE. Studies on experimental diabetes in the Wellesley hybrid mouse. IV. Morphologic changes in islet tissue. Diabetologia 1967, 3:179-187. 10.1007/BF01222196, 4907139.
98. Meier H, Yerganian G. Spontaneous hereditary diabetes mellitus in the Chinese hamster (Cricetulus griseus). III. Maintenance of a diabetic hamster colony with the aid of hypoglycemictherapy. Diabetes 1961, 10:19-21.
99. Strasser H. A breeding program for spontaneously diabetic experimental animals.: Psammomys obesus (sand rat) and Acomyscahirinus (spiny mouse). Lab Anim Care 1968, 18:328-338.
100. Dubault J, Boulanger M, Espinal J, Marquie G, Petkov P, du Boistesselin R. Latent autoimmune diabetes mellitus in adult humans with non-insulin-dependent diabetes: Is Psammomys obesus a suitable animal model?. Acta Diabetol 1995, 32:92-94. 10.1007/BF00569564, 7579541.
101. Pictet R, Orci L, Gonet AE, Rouiller C, Renold AE. Ultrastructural studies of the hyperplastic islets of Langerhans of spiny mice (Acomys cahirinus) before and during the development of hyperglycemia. Diabetologia 1967, 3:188-211. 10.1007/BF01222197, 4907140.
102. Schmidt G, Martin AP, Stuhlman RA, Townsend JF, Lucas FV, Vorbeck ML. Evaluation of hepatic mitochondrial function in the spontaneously diabetic Mystromys albicaudatus. Lab Invest 1974, 30:451-457.
103. Wise PH, Weir BJ, Hime JM, Forrest E. The diabetic syndrome in the Tuco-Tuco (Ctenomis talarum). Diabetologia 1972, 8:165-172. 10.1007/BF01212256, 4558515.
104. Howard CF. Basement membrane thickness in muscle capillaries of normal and spontaneously diabetic Macaca nigra. Diabetes 1975, 24:201-206. 10.2337/diabetes.24.2.201, 1123107.
105. Schaefer EM, Viard V, Morin J, Ferré P, Pénicaud L, Ramos P, Maika SD, Ellis L, Hammer RE. A new transgenic mouse model of chronic hyperglycemia. Diabetes 1994, 43:143-153. 10.2337/diabetes.43.1.143, 7505243.
106. Palmiter RD, Behringer RR, Quaife CJ, Maxwell F, Maxwell IH, Brinster RL. Cell lineage ablation in transgenic mice by cell-specific expression of a toxin gene. Cell 1987, 50:435-443. 10.1016/0092-8674(87)90497-1, 3649277.
107. Aichele P, Hyburtz D, Ohashi POS, Odermatt B, Zinkernagel, Hengartner H, Pircher H. Peptide-induced T-cell tolerance to prevent autoimmune diabetes in a transgenic mouse model. Proc Natl Acad Sci 1994, 91:444-448. 10.1073/pnas.91.2.444, 42965, 8290546.
108. Oldstone MBA, Nerenberg M, Southern P, Price J, Lewicki H. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 1991, 65:319-331. 10.1016/0092-8674(91)90165-U, 1901765.
109. Ohashi PS, Oehen S, Buerki K, Pircher H, Ohashi CT, Odermatt B, Malissen B, Zinkernagel RM, Hengartner H. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 1991, 65:305-317. 10.1016/0092-8674(91)90164-T, 1901764.
110. Von Herrath MG, Dockter J, Oldstone MBA. How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic mouse model. Immunity 1994, 1:231-242. 10.1016/1074-7613(94)90101-5, 7889411.
111. Von Herrath MG, Holz A. Pathological changes in the islet milieu precede infiltration of islets and destruction in β-cells by autoreactive lymphocytes in a transgenic model of virus-induced IDDM. J Autoimmun 1997, 10:231-238. 10.1006/jaut.1997.0131, 9218748.
112. Moritani M, Yoshimoto K, Ii S, Kondo M, Iwahana H, Yamaoka T, Sano T, Nakano N, Kikutani H, Itakura M. Prevention of adoptively transferred diabetes in nonobese diabetic mice with IL-10-transduced islet-specific Th1 lymphocytes: A gene therapy model of autoimmune diabetes. J Clin Invest 1996, 98:1851-1859. 10.1172/JCI118986, 507625, 8878437.
113. Matsumoto Y, Sumiya E, Sugita T, Sekimizu K. An Invertebrate Hyperglycemic Model for the Identification of Anti-Diabetic Drugs. PLoS ONE 2011, 6(3):e18292. 10.1371/journal.pone.0018292, 3068166, 21479175.
114. Higgins PB, Bastarrachea RA, Lopez-Alvarenga JC, Garcia-Forey M, Proffitt JM, Voruganti SV, Tejero ME, Mattern V, Haack K, Shade RE, Cole SA, Comuzzie AG. Eight week exposure to a high sugar high fat diet results in adiposity gain and alterations in metabolic biomarkers in baboons (Papio hamadryas sp.). Cardiovascular Diabetology 2010, 9:71. 10.1186/1475-2840-9-71, 2988722, 21034486.